SUPERNEWS - NYSE:NVO (Novo Nordisk A/S) Stock Price, News, Quote, History

SUPERNEWS

Equities

Top Stories

Novo Nordisk Enters Bond Market to Fund Expansion and Boost Production

5/14, 07:01 EDT

Novo Nordisk to Enter Bond Market for Expansion Amid Surging Demand

Novo Nordisk enters bond market to fund $11 billion expansion, buoyed by Ozempic and Wegovy's surging demand.

5/13, 08:53 EDT

Record $4.8 Billion Debt Financing Deal Fuels Novo Holdings' Catalent Acquisition

Ares and Blue Owl lead a record $4.8 billion private debt deal for Novo Holdings' acquisition of Catalent.

4/5, 18:40 EDT

Novo Down 5.3%, Amgen Up as Obesity Drug Race Heats Up

Novo Nordisk's stock falls 5.3% amid competition fears as Amgen's obesity drug MariTide shows promise, shaking up the $80 billion market.

5/3, 05:44 EDT

Denmark's Growth Forecast Doubles to 2.7%, Novo Expands

Denmark's economic growth forecast jumps to 2.7% for the year, driven by Novo Nordisk's expansion and Tyra gas field reopening.

5/16, 09:40 EDT

Novo Nordisk Enters Bond Market to Fund Expansion and Boost Production

5/14, 07:01 EDT

Novo Nordisk to Enter Bond Market for Expansion Amid Surging Demand

5/13, 08:53 EDT

Record $4.8 Billion Debt Financing Deal Fuels Novo Holdings' Catalent Acquisition

4/5, 18:40 EDT

NVO News

Denmark's Growth Forecast Doubles to 2.7%, Novo Expands

5/16, 09:40 EDT

Elevai Labs Targets $100B Anti-Obesity Market, Launches Subsidiaries

5/16, 09:03 EDT

Novo Nordisk Enters Bond Market to Fund Expansion and Boost Production

5/14, 07:01 EDT

Novo Nordisk to Enter Bond Market for Expansion Amid Surging Demand

5/13, 08:53 EDT

Amgen Surges 12% on MariTide Hopes, Eyes Obesity Market

5/6, 09:07 EDT

Novo Down 5.3%, Amgen Up as Obesity Drug Race Heats Up

5/3, 05:44 EDT

Amgen Up 12% on MariTide, Targets $80B Market by 2030

5/2, 17:49 EDT

Novo 30% Below Lilly Despite 350% Surge, Eyes Growth

5/2, 09:35 EDT

Powell's Remarks Boost US Stocks, S&P 500 Futures Up 0.6%

5/2, 05:37 EDT

Ozempic Subsidies Reduced, Novo Nordisk Drops Price in Denmark

5/1, 05:14 EDT

Novo, Stellantis Eye Gains in EMEA Amid Market Tests

4/26, 05:22 EDT

Dollar Surge Boosts Global Exporters, Goldman Notes

4/25, 07:12 EDT

Dollar Surge Boosts TSMC 32%, Exporters Gain Amid Global Shift

4/24, 22:14 EDT

Cox: Buy Health Stocks Now, Eyes on Novo & Novartis Growth

4/23, 12:21 EDT

Lansdowne Bets on Industrials, Tops 88% Peers with 14% Gain

4/23, 04:20 EDT

‘OMO’ Market Emerges Amid 3.6% S&P Growth, AI & Crypto Focus

4/12, 12:32 EDT

Pre-Market: BlackRock, Citi Outshine JPM; Tech Stocks Face China Chip Crunch

4/12, 08:55 EDT

Morgan, JPMorgan, BMO Adjust Tech & Energy Stocks Outlook

4/12, 08:32 EDT

S&P Futures Dip, Globe Life & Coupang Up Amid Market Caution

4/12, 07:52 EDT

Pre-Market: Chip Giants Stumble Amid China Shift, Globe Life Soars

4/12, 06:53 EDT

Europe's Cyclical Stocks Surge, Outshine Tech with 9% YTD Gain

4/10, 19:04 EDT

Record $4.8 Billion Debt Financing Deal Fuels Novo Holdings' Catalent Acquisition

4/5, 18:40 EDT

Europe's Top Firms Seek Equivalent to U.S.'s "Magnificent Seven" - Diverse Sectors, Common Traits

4/5, 11:12 EDT

JPMorgan Flags Bubble Risk Amid 10% Wall St Surge

3/27, 18:26 EDT

Viking Therapeutics' Weight-Loss Pill Shows Promising Results

3/26, 11:46 EDT

Amazon Pharmacy Partners with Eli Lilly to Revolutionize Drug Delivery Amid Rising Demand

3/26, 07:44 EDT

Bullish Bets Surge on Weight-Loss Drug Stocks

3/25, 09:04 EDT

Medicare's Obesity Drug Coverage Could Spike Premiums

3/21, 15:21 EDT

Oprah Winfrey's Endorsement of Obesity Drugs Sparks Debate and Interest

3/19, 05:50 EDT

Obesity Drugs' Impact on Healthcare Stocks and Related Industries

3/18, 07:31 EDT

Wall Street Views

Barclays Plc

Emily Field, 5/3/24

Neutral on

AMGN

LLY

NVO

“As of today, we see no cause for concern regarding the competitive dynamics versus the market leaders... We really will need to see the data.”

Bloomberg Intelligence

Michael Shah, 5/2/24

Bullish on

AAPL

AMGN

EXPE

“Demand for anti-obesity drugs like Zepbound and Wegovy is so insatiable that Bloomberg Intelligence’s estimate for $80 billion in annual sales by 2030 is now looking conservative.”

Principal Asset Management

George Maris, 4/24/24

Bullish on

ARGX

NVO

TSM

“Exporters to the US should benefit not only via currency translation, but also in terms of the trade advantage... They should be able to show significant margin improvements, whether they’re European or Japanese or Chinese exporters.”

Bloomberg Intelligence

Laurent Douillet, 4/24/24

Bullish on

ARGX

NVO

TSM

“Novo Nordisk A/S is certainly one with an advantage as its production is concentrated in Europe but its biggest sales market is the US.”

Invesco Asset Management

David Chao, 4/24/24

Bearish on

ARGX

NVO

TSM

“Generally, I would expect outflows when the dollar strengthens... Cyclical sectors such as basic resources, consumer discretionary firms and financials are all likely to underperform.”